Billionaires Holding KMDA

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.07
    Yield

  • 32.2M
    Shares Outstanding

  • 151.73M
    Market Cap

News & Insights

ABOUT

KMDA

Kamada Ltd. develops, produces, and markets specialty plasma-derived protein therapeutics. It operates through two segments, Proprietary Products and Distribution. The company’s respiratory products include Glassia used in augmentation and maintenance therapy in adults with emphysema due to conge...

Google parent Alphabet's earnings: $8.42 per share, vs expected EPS of $8.04

NEWS

Amazon keeps its crown as king of cloud as sales pop

READ MORE